ES522107A0 - Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido. - Google Patents

Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.

Info

Publication number
ES522107A0
ES522107A0 ES522107A ES522107A ES522107A0 ES 522107 A0 ES522107 A0 ES 522107A0 ES 522107 A ES522107 A ES 522107A ES 522107 A ES522107 A ES 522107A ES 522107 A0 ES522107 A0 ES 522107A0
Authority
ES
Spain
Prior art keywords
hydroxytiazine
carboxamide
methyl
procedure
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES522107A
Other languages
English (en)
Other versions
ES8405274A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of ES522107A0 publication Critical patent/ES522107A0/es
Publication of ES8405274A1 publication Critical patent/ES8405274A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES522107A 1982-05-08 1983-05-05 Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido. Expired ES8405274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3217315A DE3217315C2 (de) 1982-05-08 1982-05-08 Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten

Publications (2)

Publication Number Publication Date
ES522107A0 true ES522107A0 (es) 1984-06-01
ES8405274A1 ES8405274A1 (es) 1984-06-01

Family

ID=6163066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522107A Expired ES8405274A1 (es) 1982-05-08 1983-05-05 Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.

Country Status (23)

Country Link
US (1) US4482554A (es)
EP (1) EP0093999B1 (es)
JP (1) JPS5931713A (es)
KR (1) KR900008441B1 (es)
AR (1) AR230634A1 (es)
AT (1) ATE29383T1 (es)
AU (1) AU551337B2 (es)
CA (1) CA1204668A (es)
DD (1) DD211484A5 (es)
DE (2) DE3217315C2 (es)
DK (1) DK157731C (es)
ES (1) ES8405274A1 (es)
FI (1) FI79944C (es)
GR (1) GR77503B (es)
HU (1) HU197208B (es)
IE (1) IE54729B1 (es)
IL (1) IL68421A (es)
NO (1) NO163314C (es)
NZ (1) NZ204086A (es)
PH (2) PH22726A (es)
SU (1) SU1295993A3 (es)
YU (1) YU90383A (es)
ZA (1) ZA832816B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3435843A1 (de) * 1984-09-29 1986-04-03 Gödecke AG, 1000 Berlin Antirheumatisch wirksame suppositorien
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
JPH0430634Y2 (es) * 1985-06-10 1992-07-23
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
EP0318891B1 (de) * 1987-12-04 1992-01-02 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
HU205550B (en) * 1990-11-27 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
DK0560900T3 (da) * 1990-12-03 1995-05-08 Nexstar Pharmaceuticals Inc Forebyggelse af synovialadhæsioner
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1999041233A1 (en) * 1998-02-17 1999-08-19 Micio Pharma Chemical Aktiengesellschaft A watersoluble nimesulide adduct also for injectable use
CN1256807A (zh) 1998-03-14 2000-06-14 古河电气工业株式会社 输电线用散热装置、有散热装置的输电线、将散热装置装于输电线的方法
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (es) * 1967-05-18 1900-01-01
JPS4931815A (es) * 1972-07-27 1974-03-22
SE421792B (sv) * 1976-01-12 1982-02-01 Pfizer Forfarande for framstellning av n-(2-pyridyl)-4-hydroxi-2-metyl-2h-1,2-benso-tiazin-3-karboxamid-1,1-dioxid
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
KR840004509A (ko) 1984-10-22
KR900008441B1 (ko) 1990-11-22
DK204683A (da) 1983-11-09
EP0093999A2 (de) 1983-11-16
DE3217315C2 (de) 1986-05-22
AU1366483A (en) 1983-11-10
EP0093999B1 (de) 1987-09-09
IE830785L (en) 1983-11-08
DE3217315A1 (de) 1983-11-10
DE3373414D1 (en) 1987-10-15
ATE29383T1 (de) 1987-09-15
NO163314B (no) 1990-01-29
IE54729B1 (en) 1990-01-17
DK204683D0 (da) 1983-05-06
DK157731C (da) 1990-07-16
ZA832816B (en) 1983-12-28
JPS5931713A (ja) 1984-02-20
AR230634A1 (es) 1984-05-31
DD211484A5 (de) 1984-07-18
FI831534L (fi) 1983-11-09
DK157731B (da) 1990-02-12
YU90383A (en) 1988-02-29
NO163314C (no) 1990-05-09
EP0093999A3 (en) 1985-05-15
FI831534A0 (fi) 1983-05-04
FI79944B (fi) 1989-12-29
NO831610L (no) 1983-11-09
SU1295993A3 (ru) 1987-03-07
CA1204668A (en) 1986-05-20
PH22726A (en) 1988-11-28
US4482554A (en) 1984-11-13
NZ204086A (en) 1986-02-21
AU551337B2 (en) 1986-04-24
IL68421A0 (en) 1983-07-31
IL68421A (en) 1986-04-29
FI79944C (fi) 1990-04-10
JPH0257049B2 (es) 1990-12-03
PH24334A (en) 1990-05-29
ES8405274A1 (es) 1984-06-01
GR77503B (es) 1984-09-24
HU197208B (en) 1989-03-28

Similar Documents

Publication Publication Date Title
ES522107A0 (es) Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
ES520195A0 (es) Procedimiento para preparar nuevos derivados de 3-ceto- 4,9,19-nor-esteroides.
ES506893A0 (es) Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4-tetrahidro-1-naftalenami-na.
ES514016A0 (es) Procedimiento para preparar derivados de n-fenilpirazol.
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
IL56413A (en) Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them
MX14253A (es) Compuestos de amonio cuaternario, composiciones farmaceuticas que incluyen los compuestos y procedimiento para preparar los compuestos de amonio cuaternario.
IT8021370A0 (it) Derivati teofillinmetildiossolanici, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
ES510258A0 (es) Procedimiento para preparar derivados de quanadina.
ES523243A0 (es) "procedimiento para preparar derivados de 1,4-dihidropiridina".
ES527945A0 (es) Procedimiento para preparar derivados de bencilcarbamoilpiridina.
ES519702A0 (es) Procedimiento para la preparacion de 1,1-dioxidos de 3-amidino-benzoisotiazol.
FI834061A0 (fi) 2-piperazinylkinazolinderivat, framstaellning av dem och farmaceutiska kompositioner innehaollande dem
ES512397A0 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
IT1228130B (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
ES525333A0 (es) Procedimiento para preparar derivados de sulfamoilbenzofenona.
ES509734A0 (es) Procedimiento para preparar derivados de benzotiadiazol-amina.
RO84910A (ro) Procedeu pentru prepararea unor derivati 1,1-dioxizi ai acidului 6-aminoalchilpenicilanic
MX159206A (es) Procedimiento para preparar derivados de 20,21 dinoreburnamenina
ES512788A0 (es) Procedimiento para preparar derivados de 4-amino-bencilamina.
ES520624A0 (es) Un procedimiento para la preparacion de derivados de 3-cxa-1-azabiciclo (4,2,0) octano.
PT91259A (pt) Processo para a preparacao de composicoes microbicidas, contendo derivados de halogeno-vinil-azol
MX9202984A (es) Composiciones farmaceuticas que contienen salbutamol.
IT1233243B (it) Derivati dell'isochinolina.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401